QA: Evofem Biosciences Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001618835_2024_Evofem_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001618835, Evofem Biosciences Inc

  xvar xval
0 AssetsCurrent 9,210,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,203,000
3 remainder_Assets 141,000
4 LiabilitiesCurrent 72,463,000
5 LiabilitiesNoncurrent 8,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 6,835,450
8 SellingGeneralAndAdministrativeExpense 16,103,012
9 ResearchAndDevelopmentExpense 8,306,542
10 remainder_Expenses 19,500,818
11 remainder_Revenues 20,020,327
12 remainder_NetIncome 244,872,118
13 remainder_ComprehensiveNetIncome 44,347,723
  yvar yval
0 Assets 10,554,000
1 Liabilities 72,471,000
2 Expenses 50,745,822
3 Revenues 20,020,327
4 StockholdersEquity -61,917,000
5 NetIncome 214,146,623
6 ComprehensiveNetIncome 236,320,484
7 BaseVar 221,505,495
8 EconomicCapitalRatiobeforeLimitedLiability 2.44
9 EconomicCapitalRatio 3.32

Edgar->Model Mapping

Feature Distribution

Change over Time